WHEN YOU SEE IT, BE PREPARED
Generalized Pustular Psoriasis (GPP) is a rare and potentially life-threatening skin disease1 distinct from Plaque Psoriasis.2Caused by dysregulation of the IL36- pathway,3GPP flares can affect every aspect of a patient’s life, Effective, fastacting, GPP-specific therapies are needed to control them.4
![Volcano bursting through dermatologist’s door](/eg/disease/gpp/sites/default/files/2022-07/campaign-image_0.jpg)
![Doctor Icon](/eg/disease/gpp/sites/default/files/2022-06/Understanding-GPP.png)
UNDERSTANDING GPP
![Recognising GPP Flares](/eg/disease/gpp/sites/default/files/2022-06/Recognising-GPP-Flares.png)
RECOGNISING GPP FLARES
![The Impact of GPP](/eg/disease/gpp/sites/default/files/2022-06/The-Impact-of-GPP.png)
THE IMPACT OF GPP
![Pathology of GPP](/eg/disease/gpp/sites/default/files/2022-08/The-Pathology-of-GPP.png)
THE PATHOLOGY OF GPP
![The High Unmet Need of GPP](/eg/disease/gpp/sites/default/files/2022-06/The-High-Unmet-Need-of-GPP.png)
THE HIGH UNMET NEED OF GPP
GPP= Generalized Pustular Psoriasis; IL36-=interleukin36-.
REFERENCES
Choon SE, Lebwohl MG, Marrakchi S, et al. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare. BMJ Open. 2021;11(3):e043666
Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907-919.
Marrakchi S, Puig L. Pathophysiology of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022;23:13-19.
Strober B, Kotowsky N, Medeiros R, et al. Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists. Dermatol Ther (Heidelb). 2021;11(2):529-541.
Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109-120.